Autoimmune Inflammatory Reactions Triggered by the COVID-19 Genetic Vaccines in Terminally Differentiated Tissues
As a result of the spread of SARS-CoV-2, a global pandemic was declared. Indiscriminate COVID-19 vaccination has been extended to include age groups and naturally immune people with minimal danger of suffering serious complications due to COVID-19. Solid immuno-histopathological evidence demonstrates that the COVID-19 genetic vaccines can display an off-target distribution in tissues that are terminally differentiated, triggering autoimmune reactions. These include the heart and brain, which may incur in situ production of spike protein eliciting a strong autoimmunological inflammatory response. Due to the fact that every human cell which synthesizes non-self antigens becomes inevitably the target of the immune system, and since the human body is not a strictly compartmentalized system, accurate pharmacokinetic and pharmacodynamic studies are needed in order to determine precisely which tissues can be harmed. Therefore, our article aims to draw the attention of the scientific and regulatory communities on the critical need of bio-distribution studies for the genetic vaccines against COVID-19, as well as of rational harm-benefit assessments by age group..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Preprints.org - (2023) vom: 25. Sept. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Polykretis, Panagis [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.20944/preprints202303.0140.v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
preprintsorg038898101 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | preprintsorg038898101 | ||
| 003 | DE-627 | ||
| 005 | 20231205145607.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230309s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.20944/preprints202303.0140.v1 |2 doi | |
| 024 | 7 | |a 10.20944/preprints202303.0140.v1 |2 doi | |
| 035 | |a (DE-627)preprintsorg038898101 | ||
| 035 | |a (preprintsorg)10.20944/preprints202303.0140 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Polykretis, Panagis |e verfasserin |0 (orcid)0000-0001-7911-1691 |4 aut | |
| 245 | 1 | 0 | |a Autoimmune Inflammatory Reactions Triggered by the COVID-19 Genetic Vaccines in Terminally Differentiated Tissues |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a As a result of the spread of SARS-CoV-2, a global pandemic was declared. Indiscriminate COVID-19 vaccination has been extended to include age groups and naturally immune people with minimal danger of suffering serious complications due to COVID-19. Solid immuno-histopathological evidence demonstrates that the COVID-19 genetic vaccines can display an off-target distribution in tissues that are terminally differentiated, triggering autoimmune reactions. These include the heart and brain, which may incur in situ production of spike protein eliciting a strong autoimmunological inflammatory response. Due to the fact that every human cell which synthesizes non-self antigens becomes inevitably the target of the immune system, and since the human body is not a strictly compartmentalized system, accurate pharmacokinetic and pharmacodynamic studies are needed in order to determine precisely which tissues can be harmed. Therefore, our article aims to draw the attention of the scientific and regulatory communities on the critical need of bio-distribution studies for the genetic vaccines against COVID-19, as well as of rational harm-benefit assessments by age group. | ||
| 700 | 1 | |a Donzelli, Alberto |4 aut | |
| 700 | 1 | |a Lindsay, Janci C. |4 aut | |
| 700 | 1 | |a Wiseman, David |4 aut | |
| 700 | 1 | |a Kyriakopoulos, Anthony M. |0 (orcid)0000-0002-0749-0060 |4 aut | |
| 700 | 1 | |a Mörz, Michael |4 aut | |
| 700 | 1 | |a Bellavite, Paolo |0 (orcid)0000-0002-5086-3504 |4 aut | |
| 700 | 1 | |a Fukushima, Masanori |4 aut | |
| 700 | 1 | |a Seneff, Stephanie |0 (orcid)0000-0001-8191-1049 |4 aut | |
| 700 | 1 | |a McCullough, Peter A. |0 (orcid)0000-0002-0997-6355 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Preprints.org |g (2023) vom: 25. Sept. |
| 773 | 1 | 8 | |g year:2023 |g day:25 |g month:09 |
| 856 | 4 | 0 | |u https://doi.org/10.1080/08916934.2023.2259123 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.20944/preprints202303.0140.v1 |z kostenfrei |3 Volltext |
| 912 | |a preprintsorg | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 25 |c 09 | ||